ABSTRACT
Introduction
Oral lichen planus (OLP) is a common mucocutaneous lesion with chronic inflammatory progression that is presumably caused by activation of the immune response to skin or mucous changes. [1] The prevalence of this disease is 2% in the general population. [2] The etiology of lichen planus is still unknown; however, factors such as immunologic factors, genetics, medications, and hepatitis C can contribute to the pathogenesis of lichen planus. [3] Studies reported the possible transformation of this lesion to a malignant complication in long term; therefore, WHO considered this lesion as a premalignant condition. However, there is skepticism and considerable uncertainty about the premalignancy of this lesion. [4] Oral lichen planus is presented as white striations, white plaque, and erosions, which affect the oral mucosa, while erosive and atrophic forms have the most common malignant transformation. [5] Various carcinogenic percentages for oral lichen planus are reported. [6] Transformation of normal epithelium to neoplastic epithelium is the result of different genetic mutations that lead to loss of control in the mechanism of apoptosis and the subsequent changes in the differentiation of cells. In addition to the higher survival rate caused by new genetic mutations, the increased mitotic activity changes the pattern of epithelial cell maturation. [6] It was recently discovered that changes in the mechanism of cell division and apoptosis are essential for carcinogenesis. Changes in appearance, followed by the function of such proteins may be used as a marker in malignant lesions for changing a lesion to a malignant case. [6] p53 is a well-known tumor suppressor gene whose mutational inactivation is observed in many human cancers. A normal gene of p53 protein in a cell represses tumor, suppresses carcinogenesis, and prevents oncogenes proliferation activities. Cells with p53 gene have the ability to delay the cell cycle until the damaged DNA is repaired or to move the damaged cells toward cell death (apoptosis). [7] Mutations in the p53 gene are the common cause of molecular damage in human malignancy that causes cell formation with stability and incomplete half-life.
Immunohistochemical assessment of the mutant P53 expression in OLP can be considered as a risk factor in addition to other factors. [2] When the protein is mutated or absent, the cells replicate the destroyed DNA and the mutations increase. The p53 tumor suppressor mutation is the most common molecular defect in human malignancies including oral squamous cell carcinoma. [1] In a study on OLP in 2013, Oliveira et al. The percentage of stained cells in the basal layer, suprabasal layers and inflammatory infiltration was graded according to the degree of staining as follows; 0% stained cells was graded as (-), <10% (+), 10-25% (++), 26-50% (+++), and if more than 50% cell were stained it was considered (++++). The obtained results were compared and analyzed. The nuclear and cytoplasmic staining intensity by indicator were categorized in four groups including colorless or absence of any color (-), weak or light brown (+), moderate or chestnut brown (++), and severe or dark brown (+++). [10] By employing SPSS software version 15, the data were descriptively analyzed (frequency-percent). Moreover, Chi square test was used to compare the study groups regarding the expression of P53. Furthermore, Fisher's exact test was used to determine the significance of differences among the groups.
Results
This study was performed on 32 samples of OLP (16 erosive The most frequently involved area in erosive OLP group was the gingivae (50%), followed by buccal mucosa (31%) and labial mucus (19%). In non-erosive OLP group, the buccal mucosa (56%), gingivae (31%), and labial mucosa and floor of the mouth (6% each), respectively, accounted for the most affected areas. Accordingly, the percentage of p53 expression revealed a significant different between the number of cells stained in the three groups (erosive, non-erosive, and control) ( Table 1) . As presented in Table 3 , the highest and lowest mean expression of p53 was respectively observed in the erosive OLP and the control group. There were significant differences between the two study groups and the control group. The erosive and non-erosive groups
were not significantly different in in suprabasal and inflammatory infiltration locations; however, the groups were significantly different in basal location (Table 4) . 
Discussion
Oral lichen planus is a mucocutaneous disease with a chronic inflammatory process characterized by T-Cellmediated immune responses and mixed patterns of both apoptosis and increased cellular proliferation which occur simultaneously. [11] [12] [13] [14] [15] [16] Since the first case of squamous cell carcinoma was developed from a mucosal lichen planus, the true odds ratio of such transformation is a matter of discussion. In general, different
proportions of malignant potential of OLP, ranging from 0.04% to 1.74% is reported in literature. [17] It is stated that p53 plays a key role in controlling the cycle, cell differentiation, and apoptosis. [18] It is also a valuable biomarker to predict malignant transformation in premalignant oral lesions. [19] The mutation of p53 tumor suppressor gene is the most common genetic disorder ever observed in human cancers. [20] Alterations in the expression of proteins related to the regulation of apoptosis (P53) can be used as markers of In a study by Eleni et al. [16] about the correlation between p53 and lichen planus prognosis, a statistically direct correlation was observed between the p53 incidence and the clinical characteristics of lichen planus.
Moreover, more malignant changes were observed in lichen planus, as shown by p53 staining. [18] [19] This was consistent with the results of the present study.
Aghahosseini and Mirzaii [1] demonstrated that unstimulated salivary p53 values in reticular OLP patients were significantly higher than that in healthy subjects and erosive forms. They concluded that plaque in the form of OLP was important in terms of its potential for malignancy and was not a safe form. [1] A different study by Seyedmajidi et al. [9] demonstrated that no significant difference between p53 and P63 markers in the two groups of erosive and reticular lichen planus. It was consistent with Montenbugnoli et al.'s study, [3] that reported no significant difference in p53 expression between the erosive and reticular lichen planus.
The current study found the gingivae (50%) and buccal mucosa (31%) to be the most commonly involved areas in erosive OLP; whereas, the buccal mucosa (56%) and gingivae (31%) were the most affected areas in non-erosive samples. In a study by Aghahosseini et al., [17] the buccal mucosa (43.2%) was the most commonly affected site. In a study, all samples were obtained from the buccal mucosa. [20] Other studies did not explicit the locations of OLP lesions.
[17, [23] [24] The present study also detected the three groups to be significantly different regarding the color intensity of p53 marker. The color intensity was moderate in most samples of erosive OLP group, weak in most samples of non-erosive OLP group. In the normal group, most of the samples did not express the marker. None of the reviewed studies assessed the color intensity of p53 marker.
In this study, the frequency distribution of the affected area in two groups of erosive and non-erosive was examined under a microscope in terms of involvement in basal, suprabasal, and inflammatory infiltration.
The obtained P-value did not show a significant difference between the groups. However, Varma et al. [25] reported that p53 could be used as a prognostic marker in premalignant lesion. They also showed that this was presented in the basal and suprabasal layers. 
Conclusion
Since p53 is extensively accepted as an important biomarker for diagnosis, prognosis, and treatment of malignant and premalignant lesions, high expression of this marker is useful for the identification of erosive OLP lesion with a more aggressive pattern and with a major tendency to malignancy.
